Last reviewed · How we verify
Intraperitoneal and port sites infiltration
Intraperitoneal and port sites infiltration is a Small molecule drug developed by medina medical center. It is currently in Phase 1 development.
At a glance
| Generic name | Intraperitoneal and port sites infiltration |
|---|---|
| Sponsor | medina medical center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pain Relief Following Laparoscopic Cholecystectomy While Comparing Intra Abdominal Versus Sub Cutaneous Local Anesthetic Administration (PHASE4)
- "Efficacy of Local Anesthetic for Postoperative Pain in Gynecologic Laparoscopy" (NA)
- Retrolaminar Block Versus Intraperitoneal Block for Laparoscopic Cholecystectomy (NA)
- Comparison of Ultrasound-Guided Quadratus Lumborum Plane Block Versus Intraperitoneal and Periportal Bupivacaine Infiltration in Postoperative Analgesia After Laparoscopic Cholecystectomy (NA)
- The Ideal Local Anesthetic for Intraperitoneal Gallbladder Bed Infiltration Following Laparoscopic Cholecystectomy (NA)
- Gall Bladder Bed Infiltration Analgesia (NA)
- Intraperitoneal Atomization of Levobupivacaine During Gynaecological Laparoscopic Procedures ; Impact on Pain, Opioid Use and Length of Recovery Room Stay (IPLA). (PHASE4)
- Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intraperitoneal and port sites infiltration CI brief — competitive landscape report
- Intraperitoneal and port sites infiltration updates RSS · CI watch RSS
- medina medical center portfolio CI
Frequently asked questions about Intraperitoneal and port sites infiltration
What is Intraperitoneal and port sites infiltration?
Intraperitoneal and port sites infiltration is a Small molecule drug developed by medina medical center.
Who makes Intraperitoneal and port sites infiltration?
Intraperitoneal and port sites infiltration is developed by medina medical center (see full medina medical center pipeline at /company/medina-medical-center).
What development phase is Intraperitoneal and port sites infiltration in?
Intraperitoneal and port sites infiltration is in Phase 1.